Both in Pharmaceuticals
Anixa Biosciences vs Minerva Neurosciences
Over the past year ANIX returned −26.2% and NERV returned −38.5%; their daily moves had a correlation of 0.21.
ANIX −26.2% NERV −38.5%Growth of $1, one year, split-adjusted
| Metric | ANIX | NERV |
|---|---|---|
| Price | $3.06 | $2.35 |
| Market cap | $106.2M | $112.2M |
| Today | +2.17% | +0.21% |
| 1 month | +3.6% | −29.2% |
| 6 months | +1.8% | −62.4% |
| Year to date | −2.1% | −41.5% |
| 1 year | −26.0% | −44.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $13.9M | $75.3M |
| Dividend yield | — | — |
| Volatility (60d) | 58.8% | 78.0% |
| Short % of float | 7.4% | 6.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).